Literature DB >> 27743743

Gemcitabine-Associated Thrombotic Microangiopathy: Response to Complement Inhibition and Reinitiation of Gemcitabine.

Jeffrey L Turner1, Joshua Reardon2, Tanios Bekaii-Saab3, Spero R Cataland4, Matthew J Arango5.   

Abstract

Entities:  

Keywords:  Drug-induced thrombotic microangiopathy; Eculizumab; Hemolytic uremic syndrome; Pancreatic cancer; Toxicity

Year:  2016        PMID： 27743743     DOI： 10.1016/j.clcc.2016.09.004

Source DB:  PubMed          Journal:  Clin Colorectal Cancer        ISSN： 1533-0028            Impact factor:   4.481


× No keyword cloud information.
  6 in total

1.  Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort.

Authors:  Florence Daviet; Franck Rouby; Pascale Poullin; Julie Moussi-Francès; Marion Sallée; Stéphane Burtey; Julien Mancini; Florence Duffaud; Renaud Sabatier; Bertrand Pourroy; Aurélie Grandvuillemin; Steven Grange; Véronique Frémeaux-Bacchi; Paul Coppo; Joëlle Micallef; Noémie Jourde-Chiche
Journal:  Br J Clin Pharmacol       Date:  2018-12-18       Impact factor: 4.335

2.  ASFA Category IV becomes Category I: Idiopathic thrombotic thrombocytopenic purpura in a patient with presumed gemcitabine-induced thrombotic microangiopathy.

Authors:  Peter G Bittar; Myles S Nickolich; Oluwatoyosi A Onwuemene
Journal:  J Clin Apher       Date:  2017-09-23       Impact factor: 2.821

3.  Neurological variability in chemotherapy-induced posterior reversible encephalopathy syndrome associated with thrombotic microangiopathy: Case reports and literature review.

Authors:  Chen Makranz; Salome Khutsurauli; Yosef Kalish; Ruth Eliahou; Luna Kadouri; John Moshe Gomori; Alexander Lossos
Journal:  Mol Clin Oncol       Date:  2017-11-02

4.  Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre.

Authors:  Maximilien Grall; Florence Daviet; Noémie Jourde Chiche; François Provot; Claire Presne; Jean-Philippe Coindre; Claire Pouteil-Noble; Alexandre Karras; Dominique Guerrot; Arnaud François; Ygal Benhamou; Agnès Veyradier; Véronique Frémeaux-Bacchi; Paul Coppo; Steven Grangé
Journal:  BMC Nephrol       Date:  2021-07-21       Impact factor: 2.388

5.  The use of eculizumab in gemcitabine induced thrombotic microangiopathy.

Authors:  Vinod Krishnappa; Mohit Gupta; Haikoo Shah; Abhijit Das; Natthavat Tanphaichitr; Robert Novak; Rupesh Raina
Journal:  BMC Nephrol       Date:  2018-01-12       Impact factor: 2.388

6.  Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.

Authors:  Vicky Brocklebank; David Kavanagh
Journal:  Clin Kidney J       Date:  2017-05-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.